Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam
Vaccines are strongly recommended globally as an effective measure to prevent serious illness from and spread of COVID-19. Concerns about safety following vaccination continue to be the most common reason that people do not accept the vaccine. This retrospective study was carried out on 4341 people who received the first dose of ChAdOx1 nCoV-19, BBIBP-CorV, or mRNA-1273 vaccine at Jio Health Clinic in Ho Chi Minh City, Vietnam. Post-injection side effects were either reported by participants or actively collected by health care staff by means of telemedicine. Local side effects were reported by 35.5% of all individuals, with pain being the most common symptom (33.3%). Systemic side effects were reported by 44.2% of individuals, with fever (25.3%) and fatigue (21.4%) being the most common. Age ≤60 years, female gender, and ChAdOx1 nCoV-19 were significant independent risk factors for both local and systemic side effects, while a history of allergy was significant as a risk factor for local side effects. A total of 43 individuals (1.0%) reported concerning symptoms of rare severe complications, which were addressed and treated by physicians via Jio Health app.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Human vaccines & immunotherapeutics - 19(2023), 1 vom: 31. Dez., Seite 2176066 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nguyen, Si Van [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019-nCoV Vaccine mRNA-1273 |
|---|
| Anmerkungen: |
Date Completed 16.03.2023 Date Revised 30.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/21645515.2023.2176066 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353620858 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353620858 | ||
| 003 | DE-627 | ||
| 005 | 20231226210035.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/21645515.2023.2176066 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1178.xml |
| 035 | |a (DE-627)NLM353620858 | ||
| 035 | |a (NLM)36856074 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nguyen, Si Van |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.03.2023 | ||
| 500 | |a Date Revised 30.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Vaccines are strongly recommended globally as an effective measure to prevent serious illness from and spread of COVID-19. Concerns about safety following vaccination continue to be the most common reason that people do not accept the vaccine. This retrospective study was carried out on 4341 people who received the first dose of ChAdOx1 nCoV-19, BBIBP-CorV, or mRNA-1273 vaccine at Jio Health Clinic in Ho Chi Minh City, Vietnam. Post-injection side effects were either reported by participants or actively collected by health care staff by means of telemedicine. Local side effects were reported by 35.5% of all individuals, with pain being the most common symptom (33.3%). Systemic side effects were reported by 44.2% of individuals, with fever (25.3%) and fatigue (21.4%) being the most common. Age ≤60 years, female gender, and ChAdOx1 nCoV-19 were significant independent risk factors for both local and systemic side effects, while a history of allergy was significant as a risk factor for local side effects. A total of 43 individuals (1.0%) reported concerning symptoms of rare severe complications, which were addressed and treated by physicians via Jio Health app | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a BBIBP-CorV | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a ChAdOx1 nCov-19 | |
| 650 | 4 | |a mRNA-1273 | |
| 650 | 4 | |a side effects | |
| 650 | 4 | |a telemedicine | |
| 650 | 4 | |a vaccine | |
| 650 | 7 | |a 2019-nCoV Vaccine mRNA-1273 |2 NLM | |
| 650 | 7 | |a EPK39PL4R4 |2 NLM | |
| 650 | 7 | |a BIBP COVID-19 vaccine |2 NLM | |
| 650 | 7 | |a ChAdOx1 nCoV-19 |2 NLM | |
| 650 | 7 | |a B5S3K2V0G8 |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Nguyen, Bay Thi |e verfasserin |4 aut | |
| 700 | 1 | |a Duong, Huong Nguyen Viet |e verfasserin |4 aut | |
| 700 | 1 | |a Lenh, Phong Thanh |e verfasserin |4 aut | |
| 700 | 1 | |a Tran, Kien Trung |e verfasserin |4 aut | |
| 700 | 1 | |a Tran, Hoa Minh |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Thanh Cong |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Dung Phuong |e verfasserin |4 aut | |
| 700 | 1 | |a Ta, My Ngoc |e verfasserin |4 aut | |
| 700 | 1 | |a Trieu, Nhut Nguyen Minh |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Nam Ba |e verfasserin |4 aut | |
| 700 | 1 | |a Tran, Hung Quang |e verfasserin |4 aut | |
| 700 | 1 | |a Tran, Son Thanh |e verfasserin |4 aut | |
| 700 | 1 | |a Rai, Raghu |e verfasserin |4 aut | |
| 700 | 1 | |a Pham, An Le |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Human vaccines & immunotherapeutics |d 2012 |g 19(2023), 1 vom: 31. Dez., Seite 2176066 |w (DE-627)NLM21576823X |x 2164-554X |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2023 |g number:1 |g day:31 |g month:12 |g pages:2176066 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/21645515.2023.2176066 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2023 |e 1 |b 31 |c 12 |h 2176066 | ||